Skin cream treatment for small early non-melanoma skin cancers
Treatments studied
Part of Cancer, Skin clinical trials.
This study tests whether 5-fluorouracil and calcipotriene (medicines used on the skin) can treat certain small, early skin cancers or pre-cancers without surgery. It’s for specific types and locations of lesions and aims to see how well the treatment works and how safe it is.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need to speak English and be able to follow study instructions and visits.
- You have an un-treated, biopsy-proven superficial basal cell cancer (sBCC) or squamous cell carcinoma in situ (SCCis).
- Your lesion must be small (less than 2 cm) and located on the scalp, trunk, neck, or arms/legs (excluding hands, feet, and genital area)—OR you have certain lesions on face/hands/feet/genital area where surgery isn’t possible.
- You must not have had treatment right at the spot before (including “field” skin treatments within 2 cm) and no radiation to that area.
- If you can become pregnant, you must take a pregnancy test before starting and use birth control during treatment; you cannot be pregnant or breastfeeding.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1/2 trial tests EscharEx (an investigational treatment) to see if it is safe and works on a single small basal cell skin cancer on the trunk or upper arms. You might qualify if your cancer fits specific size and location rules and you have not had radiation to that spot.
This study tests if a cream applied to the face can stop new basal cell cancers from forming. It is for veterans who have had two or more basal cell cancers in the past five years, with at least one on the face or scalp.
This trial tests a device placed on skin cancer lesions to see which drugs might work best. It is for people with visible squamous cell carcinoma on the skin, including lesions that have come back after radiation.
This early-phase study tests whether combining an injection into the skin lesion with a topical cream can treat squamous cell skin cancer. It may help shrink the cancer and improve control in people whose tumor is in the lower legs or feet.
This trial tests if adding calcipotriol to a standard chemotherapy cream (5-fluorouracil) works better than the standard cream alone for treating actinic keratosis (precancerous sun-damaged skin spots). You may qualify if you have at least four spots on your face, scalp, neck, chest, or arms.
This trial tests combining a skin cream (imiquimod), a laser treatment, and an immunotherapy drug (cemiplimab) before surgery for high-risk basal cell carcinoma. The goal is to see if this combination shrinks tumors enough to make surgery less disfiguring or damaging to nearby functions.
Hear when a new Superficial Basal Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.